News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
08-Nov-2010 - BioCurex Inc. announced that it has filed a new patent within the Patent Cooperation Treaty, which presently includes 142 countries. The subject of this patent is a synthetic peptide that recognizes RECAF™ and that can replace the antibodies used in BioCurex's RECAF test. The synthetic peptide ...
09-Jul-2010 - BioCurex Inc. announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy ...
10-Nov-2008 - BioCurex Inc. as incorporated a fully-owned subsidiary, BioCurex China, in Shanghai. This followed a lengthy legal process - required of all foreign companies - that took several months to complete. The subsidiary will initially operate as a clinical laboratory for RECAF testing and will serve ...
19-Sep-2008 - BioCurex Inc. announced that the Australian Patent Office has issued a notice of acceptance for a divisional application of our original patent filing. This is the first patent awarded to BioCurex for the development of therapeutic applications of its RECAF technology. All proprietary protection ...
31-Jul-2008 - BioCurex Inc. announced that it has filed a new patent application to protect certain methods of purifying and detecting RECAF in bodily fluids. The patent application also includes what the company believes - based on available information - to be new methods for tumor imaging and therapy based ...
28-Mar-2008 - BioCurex Inc. announced that the European Patent Office (EPO) has granted the Company's patent claims for cancer diagnostic serum tests based on the RECAF marker. A ``continuation in part'' patent application (also referred to as a ``divisional'') has been filed with the EPO in relation to ...
11-Jan-2008 - BioCurex and Inverness Medical Innovations have announced a licensing agreement for BioCurex's RECAF material and technology. RECAF (the receptor for alpha-fetoprotein) is a wide-spectrum marker present in malignant cancer cells and absent in most normal cells, allowing it to play a major role in ...
27-Sep-2007 - Dr. Stewart Sell, a member of BioCurex's Scientific Advisory Board, has been awarded the prestigious ISOBM-Abbott award for his lifetime achievements in cancer research, immunology, developmental biology, and stem cell research. Dr. Sell's achievements go beyond research, since he is an excellent ...
19-Feb-2007 - BioCurex Inc. announced that is has started development of a 'point-of-care' RECAF test which would be available for use at the doctor's office rather than in a laboratory setting. During the past two quarters, the Company has been engaged in converting its original radioactive-labeled RECAF ...
11-Dec-2006 - BioCurex Inc. announced that it has signed a collaboration agreement with the Blokhin Cancer Research Center in Moscow, Russia, for further development and evaluation of its RECAF(TM) technology. This new phase of the BioCurex/Blokhin collaboration is centered on the use of the RECAF marker for ...
© 1997-2024 LUMITOS AG, All rights reserved